【医疗新应用:首款3D打印药片获批】

【医疗新应用:首款3D打印药片获批】Aprecia Pharmaceuticals公司宣布FDA批准首款3D打印药物SPRITAM上市。该药物用于治疗癫痫,渗透性高,只需少量水就能使药品快速溶解,对不易吞咽药品的患者十分有效。3D打印技术一直都应用于医疗领域,如3D假肢、3D打印植入体、3D打印器官移植等。

First 3D-printed drug approved by FDA

150804110805-aprecia-3d-printed-drug-780x439
For the first time ever, the U.S. Food and Drug Administration has approved a 3D-printed drug.
The prescription pill, Spritam levetiracetam, will be used to treat certain types of seizures in epilepsy patients.
The drug's manufacturer, Aprecia Pharmaceuticals, says it makes the oral medication through a three-dimensional printing process, which builds the pill by spreading layers of the drug on top of one another until the right dosage is reached.
This technique allows the pill to deliver a higher dosage of medicine -- up to 1,000 milligrams -- while being porous enough to dissolve quickly. These attributes can be particularly beneficial for patients who have a hard time swallowing their medication, and miss doses of treatment, the company says.
"As a result, Spritam enhances the patient experience -- administration of even the largest strengths of levetiracetam with just a sip of liquid," Aprecia said in a statement on Monday. "In addition, with Spritam there is no measuring required as each dose is individually packaged, making it easy to carry this treatment on the go."
Aprecia says it expects the drug to be available early next year for adults and children.
Over the past few years, medical researchers have been experimenting with 3D printing technology for all kinds of applications, such as organ transplants, tissue regeneration, and replacement bones and prosthetics.
Commercial uses have also been growing. Everything from toys to spare mechanical parts, and food and fashion have been made using a 3D printing process.

http://money.cnn.com/2015/08/04/technology/fda-3d-printed-drug-epilepsy/index.html


Comments are closed.



无觅相关文章插件